Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
JDR Clin Trans Res ; 7(1_suppl): 31S-39S, 2022 10.
Article in English | MEDLINE | ID: covidwho-2043094

ABSTRACT

KNOWLEDGE TRANSFER STATEMENT: The results of this study can help key stakeholders, such as health care facilities, educational and research institutions, insurance companies, and governmental bodies, plan future activities and policies on dental practice and education.


Subject(s)
Oral Health , Scope of Practice , Delivery of Health Care , Education, Dental , Forecasting
2.
Res Social Adm Pharm ; 18(9): 3638-3648, 2022 09.
Article in English | MEDLINE | ID: covidwho-1773752

ABSTRACT

BACKGROUND: In response to the COVID-19 pandemic, many pharmacy-based or pharmacist-delivered services were introduced or amended to mitigate the pandemic's health and social impact. This happened within the context of pharmacists seeking more opportunities to increase their clinical responsibilities and play a larger role in primary care. OBJECTIVE(S): To analyse the policymaking context and pharmacy responses to COVID-19 that enable or constrain the expansion of pharmacists' scope of practice. METHODS: This study is a policy analysis of documentary data detailing changes in pharmacy policy in Australia, drawing on a "policy space analysis" framework to identify opportunities and constraints to policy reform. Data were collected from news for health professionals; federal/jurisdictional legislation and media releases; and guidelines and directives from government health departments and agencies. Changes to pharmacy practice were identified and classified according to type. For each change, potential opportunities and constraints for expanding pharmacists' scope of practice were identified. RESULTS: Four categories of changes were identified: medicines limits/restrictions; alternatives to paper prescriptions; public health measures; and community pharmacist-delivered services. Opportunities from the pandemic response that could expand scope of practice include the potential permanence of temporary measures that increase pharmacists' responsibilities; remuneration to legitimise services; political acknowledgement of medicines safety and access as a priority; and government need to quickly address crises. Constraints include the potential permanence of temporary measures that restrict pharmacists' practice; negative perceptions of pharmacists from other clinicians; intra-professional disagreements regarding pharmacy-based services; and lack of pharmacist representation in institutional structures. CONCLUSIONS: This analysis demonstrates that the pandemic responses and policy context may facilitate expansion of pharmacists' scope of practice, and identifies possible avenues to do so; it also highlights constraints that need to be further addressed to achieve this goal.


Subject(s)
COVID-19 , Community Pharmacy Services , Attitude of Health Personnel , COVID-19/epidemiology , Humans , Pandemics , Pharmacists , Professional Role , Scope of Practice
4.
Ophthalmic Physiol Opt ; 42(3): 428-439, 2022 05.
Article in English | MEDLINE | ID: covidwho-1685396

ABSTRACT

PURPOSE: As the landscape in ophthalmology and related commissioning continues to change, there is a pressing need to re-evaluate the current scope of practice of hospital optometrists working within secondary care in the UK. We aim to establish if the skills or services delivered by optometrists have changed to meet varying demands, and to better understand what changes in practice may have arisen as a result of COVID-19. METHOD: A survey developed from that used in 2015 was disseminated to 129 optometry Hospital Eye Service (HES) leads in September 2020, including questions on department workforce; core services; extended roles; procedures undertaken within extended roles; level of autonomy; arrangements for prescribing; training and accreditation, and service changes in response to COVID-19. RESULTS: Ninety responses were received (70% response rate) from within England (76%), Scotland (22%) and Northern Ireland (2%). Whole time equivalents within units ranged from 0.4-79.2 (median of 2.5). In comparison to the 2015 survey, there was an increase in the proportion of units delivering extended roles, with glaucoma (88%) remaining the most common extended role, and new areas of practice in uveitis (21%) and vitreoretinal (13%) services. There was increased use of independent prescribing (67%) in comparison to 18% in 2015 and there was an increase in optometrists delivering laser interventions. In response to COVID-19, optometrists were increasingly delivering telephone consultations and there were new collaborations between primary and secondary care. CONCLUSIONS: Optometrists' scope of practice continues to develop in the HES with an increased variety of roles and an apparent increase in the number of units employing optometrists, often working in roles historically performed by medical practitioners. Such changes appear necessary in recovery and transformation within ophthalmology, alongside wider optometry changes arising at the interface of primary and secondary care.


Subject(s)
COVID-19 , Optometrists , Optometry , COVID-19/epidemiology , Hospitals , Humans , Optometry/methods , Scope of Practice , United Kingdom/epidemiology
5.
Nurs Outlook ; 70(1): 28-35, 2022.
Article in English | MEDLINE | ID: covidwho-1347782

ABSTRACT

BACKGROUND: During the COVID-19 pandemic, federal and state governments removed the scope of practice restrictions on nurse practitioners (NPs), allowing them to deliver care to patients without restrictions. PURPOSE: To support policy makers' efforts to grant full practice authority to NPs beyond the COVID-19 pandemic, this manuscript summarizes the existing evidence on the benefits of permanently removing state-level scope of practice barriers and outline recommendations for policy, practice, and research. METHODS: We have conducted a thorough review of the existing literature. FINDINGS: NP full scope of practice improves access and quality of care and leads to better patient outcomes. It also has the potential to reduce health care cost. DISCUSSION: The changes to support full practice authority enacted to address COVID-19 are temporary. NP full practice authority could be part of a longer-term plan to address healthcare inequities and deficiencies rather than merely a crisis measure.


Subject(s)
Nurse Practitioners/legislation & jurisprudence , Practice Patterns, Nurses'/trends , Primary Health Care , Scope of Practice/legislation & jurisprudence , State Government , COVID-19 , Federal Government , Health Services Accessibility , Humans , Scope of Practice/trends
6.
J Nurses Prof Dev ; 37(3): 176-182, 2021.
Article in English | MEDLINE | ID: covidwho-1246815

ABSTRACT

A two-phase research study was conducted to inform the upcoming fourth edition of Nursing Professional Development: Scope and Standards of Practice. This column describes Phase 1, which used a virtual world café methodology to gather qualitative data from 32 nursing professional development experts. Eighteen themes emerged from the data supporting the six responsibilities of the nursing professional development practitioner. Researchers found the virtual world café to be a useful technique for eliciting expert opinions.


Subject(s)
Internationality , Nurses , Scope of Practice , Staff Development/trends , Humans , Specialties, Nursing
7.
Am J Manag Care ; 27(5): 212-216, 2021 05.
Article in English | MEDLINE | ID: covidwho-1232750

ABSTRACT

OBJECTIVES: To determine whether enough primary care providers are in close proximity to where dual-eligible beneficiaries live to provide the capacity needed for integrated care models. STUDY DESIGN: Secondary data analysis using dual-eligible enrollment data and health care workforce data. METHODS: We determined the density of dual-eligible beneficiaries per 1000 population in 2017 for each of 3142 US counties. County-level supply of primary care physicians (PCPs), primary care nurse practitioners, and physician assistants was determined. RESULTS: One-third of the 791 counties with the highest density of dual-eligible beneficiaries had PCP shortages. Counties with the highest density of dual-eligible beneficiaries and the fewest primary care clinicians of any type were concentrated in Southeastern states. These areas also had some of the highest coronavirus disease 2019 outbreaks within their states. CONCLUSIONS: States in the Southeastern region of the United States with some of the most restrictive scope-of-practice laws have an inadequate supply of primary care providers to serve a high concentration of dual-eligible beneficiaries. The fragmented care of the dually eligible population leads to extremely high costs, prompting policy makers to consider integrated delivery models that emphasize primary care. However, primary care workforce shortages will be an enduring challenge without scope-of-practice reforms.


Subject(s)
Delivery of Health Care, Integrated/standards , Health Services Accessibility/standards , Nurse Practitioners/supply & distribution , Physician Assistants/supply & distribution , Physicians, Primary Care/supply & distribution , Primary Health Care , Scope of Practice/legislation & jurisprudence , Humans , Medicaid , Medicare , United States
8.
Prehosp Emerg Care ; 25(5): 724-729, 2021.
Article in English | MEDLINE | ID: covidwho-1214290

ABSTRACT

Position Statement and Resource document approved by the NAEMSP Board of Directors on April 27, 2021.


Subject(s)
Emergency Medical Services , Curriculum , Humans , Scope of Practice
10.
Nurs Outlook ; 69(3): 333-339, 2021.
Article in English | MEDLINE | ID: covidwho-1042463

ABSTRACT

BACKGROUND: The coronavirus disease 2019 (COVID-19) disrupted the education and clinical training of nursing students. Clinical sites shut out students over low equipment supplies, physical distancing requirements, and redeployment of staff. PURPOSE AND METHODS: The purpose of this paper is to highlight a progressive solution to engage nurse practitioner students as part of the COVID-19 response given the disruption of their traditional clinical training environments so that student could continue to matriculate and graduate in a timely manner. FINDINGS: Nurse practitioner students swiftly responded and were deemed an essential part of the nursing workforce. DISCUSSION: Policy implications for advanced nursing practice and education for telehealth and simulation research moving forward is also provided.


Subject(s)
COVID-19 , Health Workforce , Nurse Practitioners/education , Students, Nursing , Telemedicine , Triage , Education, Nursing, Graduate , Humans , Scope of Practice
11.
Med Care Res Rev ; 78(1_suppl): 4S-6S, 2021 02.
Article in English | MEDLINE | ID: covidwho-904997

ABSTRACT

The health workforce has been greatly affected by COVID-19. In this commentary, we describe the articles included in this health workforce research supplement and how the issues raised by the authors relate to the COVID-19 pandemic and rapidly changing health care environment.


Subject(s)
COVID-19/epidemiology , Health Services Accessibility , Health Workforce/trends , Scope of Practice , Humans , Surge Capacity
13.
Am J Nurs ; 120(8): 14, 2020 08.
Article in English | MEDLINE | ID: covidwho-681207
14.
Clin Imaging ; 67: 192-193, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-671827

ABSTRACT

The recent COVID-19 pandemic has impacted every facet of life and placed a significant strain on healthcare resources worldwide. One of the emerging themes of medicine's response to the outbreak is doing more with less. In certain parts of the world, the toll on healthcare workers has been immense, and practicing outside one's traditional scope and comfort zone has become the rule rather than the exception. For Radiology as a discipline, the stress of COVID-19 may be comparatively small when measured against the frontline physicians and nurses in the Emergency Department and Intensive Care Unit. Still, it is incumbent upon all disciplines to learn and grow from the challenges encountered during this crisis.


Subject(s)
Clinical Competence , Coronavirus Infections , Pandemics , Pneumonia, Viral , Radiography , Radiologists , Radiology , Scope of Practice , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Health Personnel , Humans , Learning , Pneumonia, Viral/epidemiology , Pneumonia, Viral/virology , SARS-CoV-2
15.
Subst Abus ; 41(3): 269-274, 2020.
Article in English | MEDLINE | ID: covidwho-663228

ABSTRACT

Medications for opioid use disorder (MOUD), such as methadone and buprenorphine, are effective strategies for treatment of opioid use disorder (OUD) and reducing overdose risk. MOUD treatment rates continue to be low across the US, and currently, some evidence suggests access to evidence-based treatment is becoming increasingly difficult for those with OUD as a result of the 2019 novel corona virus (COVID-19). A major underutilized source to address these serious challenges in the US is community pharmacy given the specialized training of pharmacists, high levels of consumer trust, and general availability for accessing these service settings. Canadian, Australian, and European pharmacists have made important contributions to the treatment and care of those with OUD over the past decades. Unfortunately, US pharmacists are not permitted to prescribe MOUD and are only currently allowed to dispense methadone for the treatment of pain, not OUD. US policymakers, regulators, and practitioners must work to facilitate this advancement of community pharmacy-based through research, education, practice, and industry. Advancing community pharmacy-based MOUD for leading clinical management of OUD and dispensation of treatment medications will afford the US a critical innovation for addressing the opioid epidemic, fallout from COVID-19, and getting individuals the care they need.


Subject(s)
Analgesics, Opioid/therapeutic use , Community Pharmacy Services , Opiate Substitution Treatment , Opioid-Related Disorders/drug therapy , Pharmacists , Scope of Practice , Australia , Betacoronavirus , Buprenorphine/therapeutic use , COVID-19 , Canada , Coronavirus Infections , Delivery of Health Care , Health Services Accessibility , Humans , Methadone/therapeutic use , Pandemics , Pneumonia, Viral , SARS-CoV-2 , United Kingdom , United States
SELECTION OF CITATIONS
SEARCH DETAIL